EGFR and non-small cell lung carcinoma: CTNNB1 co-mutation has been described to be more frequent in EGFR-mutated NSCLC than in wild-type EGFR [25] and its absence has been associated with a poor prognosis in EGFR-mutated NSCLC [26].